Overview
Nionyx Bio is based in New York, NY [1] and develops gene therapies for genetic kidney diseases using engineered AAV vectors designed to target kidney cells [4]. The company is backed by 2048 Ventures [2].
The company's own website places it in New York: Company explicitly states 'New York, NY' in footer/company information section. [1]
Something wrong or missing? Send an update. Fixed within 24 hours.